Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.

← Back to Medmonitor

Medication Type: Diabetes

ZEGALOGUE^® (DASIGLUCAGON) INJECTION FOR SUBCUTANEOUS USE

Approval Date: Mar 2021

Note: New Product

For the treatment of severe hypoglycemia in diabetic patients

« Previous 1 2

Medication Name

Approval Date

Category

Description

ZEGALOGUE^® (DASIGLUCAGON) INJECTION FOR SUBCUTANEOUS USE

Mar 2021

For the treatment of severe hypoglycemia in diabetic patients

Note: New Product

« Previous 1 2

Workers' Comp Property and Casualty PBM
Expires 01/01/2028